Oncolytic Virus

A virus is said to be oncolytic if it targets cancer cells for infection and then proceeds to destroy those cells. As a result of the oncolysis, infected cancer cells are being eliminated, which results in the production of additional infectious virus particles called virions, which further contribute to the elimination of the residual tumor. It is believed that oncolytic viruses not only induce the direct killing of tumor cells, but also activate the host's anti-tumor immune system responses. [Citation needed] [Citation needed] In addition to this, oncolytic viruses are able to influence the microenvironment of the tumor in a variety of different ways.

How You Will Benefit

(I) Insights, and validations about the following topics:

Chapter 1: Oncolytic virus

Chapter 2: Virotherapy

Chapter 3: Virus latency

Chapter 4: Herpes simplex virus

Chapter 5: Tony Minson

Chapter 6: Genetically modified virus

Chapter 7: Pelareorep

Chapter 8: Pexastimogene devacirepvec

Chapter 9: Herpes simplex research

Chapter 10: Jennerex

Chapter 11: Talimogene laherparepvec

Chapter 12: Oncolytic herpes virus

Chapter 13: Oncolytic adenovirus

Chapter 14: GL-ONC1

Chapter 15: Genelux Corporation

Chapter 16: ONCOS-102

Chapter 17: Akseli Hemminki

Chapter 18: Infected cell protein 34.5

Chapter 19: Oncolytic AAV

Chapter 20: HSV epigenetics

Chapter 21: Transgene (company)

(II) Answering the public top questions about oncolytic virus.

(III) Real world examples for the usage of oncolytic virus in many fields.

(IV) 17 appendices to explain, briefly, 266 emerging technologies in each industry to have 360-degree full understanding of oncolytic virus' technologies.

Who This Book Is For

Professionals, undergraduate and graduate students, enthusiasts, hobbyists, and those who want to go beyond basic knowledge or information for any kind of oncolytic virus.